Inflammatory parameters and prediction of prognosis in infective endocarditis
Open Access
- 15 June 2013
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 13 (1) , 272
Abstract
Procalcitonin (PCT) is widely used in critically ill patients to diagnose clinically significant infection and sepsis. Aim of this study was to evaluate the prognostic value of PCT in comparison to white blood cell count (WBC) and C-reactive protein (CRP) for clinical outcome and its correlation with microbiological etiology in patients with infective endocarditis (IE). A retrospective single-center analysis was performed from 2007 till 2009. All patients were diagnosed having IE according to Duke standard criteria. Before starting antibiotic therapy, WBC, CRP and PCT were measured and blood cultures were taken for microbiological diagnosis of the etiological pathogen. Patients were followed up during in-hospital stay for poor outcome, defined as death or serious complications due to IE. During the study period 50 patients (57 ± 17 years, 72% male) fulfilling Duke criteria for IE were identified. In all patients PCT measurements before start of antibiotic therapy were available. In ROC analysis, a cut-off for PCT > 0.5 ng/mL was most accurate for the prediction of poor outcome with a sensitivity of 73% and specificity of 79%, a positive predictive value of 79% and a negative predictive value of 73%. Patients with a PCT > 0.5 ng/mL had an odds ratio of 12.8 (95% CI 2.5 – 66.2) for finding Staphylococcus aureus in blood cultures. For the first time, this study shows that in IE, an initial value of PCT > 0.5 ng/mL is a useful predictor of poor outcome, i.e. death or serious infectious complications. PCT > 0.5 ng/mL should raise the suspicion of Staphylococcus aureus as the etiological pathogen, whereas PCT levels < 0.5 ng/mL make staphylococcal infection unlikely.Keywords
This publication has 29 references indexed in Scilit:
- Comparison of the clinical application of reactive oxygen species and inflammatory markers in patients with endocarditisArchives of Medical Science, 2012
- Procalcitonin in 759 Patients Clinically Suspected of Infective EndocarditisThe American Journal of Medicine, 2010
- Relation of Level of B-Type Natriuretic Peptide With Outcomes in Patients With Infective EndocarditisThe American Journal of Cardiology, 2010
- Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP – Results from the German competence network CAPNETZRespiratory Research, 2009
- Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediatorsEuropean Respiratory Journal, 2007
- Utility of serum C-reactive protein in assessing the outcome of infective endocarditisEuropean Heart Journal, 2005
- Procalcitonin and the Early Diagnosis of Infective EndocarditisCirculation, 2004
- Risk factors for “major” embolic events in hospitalized patients with infective endocarditisAmerican Heart Journal, 2003
- New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findingsThe American Journal of Medicine, 1994
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993